Use of peripheral venous access devices for obtaining blood samples for measurement of activated partial thromboplastin times.

A correct activated partial thromboplastin time is crucial for the management of patients receiving continuous intravenous heparin therapy. In this study, the accuracy of peripheral venous access devices for measurement of activated partial thromboplastin times is examined.